For three decades, conservatives abandoned science policy. Now they have a chance to rebuild it.

That rebuilding effort comes with political challenges. Republicans' trust in science dropped thirty points over those decades. DOGE recently  slashed budgets at the National Science Foundation and National Institutes of Health. And HHS Sec RFK jr. is casting doubt on the efficacy of vaccines to the alarm of many Republicans in Congress. But beyond the politics, American science is also facing a competitive threat from China. The Middle Kingdom invests tens of billions in biotech and quantum computing, and outpaces the U.S. in PhD STEM grads.

Meanwhile, American research became a system that rewards process over results. Researchers spend 42% of their time on paperwork. Only 46% of cancer studies could be replicated. And our guest today argues that perverse incentives and bureaucracy led to decades wasted on Alzheimer’s research that turned out to be fraudulent—among other misfires.

Ian Banks is Director of Science Policy at the Foundation for American Innovation, which recently established the science program he leads at the organization. He and Evan discuss his vision for a renewed conservative approach to science—one that learns from diversified investment portfolios that maintain safe bets while also making room for moonshots. They get into the political challenges created by hot button issues like climate change and COVID response, how to properly fund science in the era of DOGE, and what the proper role for politics in science should be.

Previously, Banks served in research roles at the Conservative Coalition for Climate Solutions, the American Enterprise Institute and as a legislative aide to Rep. Bill Posey, where he focused on science, energy, and health policy. His Oxford master's thesis examined the replication crisis, and he brings firsthand experience navigating these questions during COVID from his time working on the Hill.